US EPA approves Byotrol24 as long-lasting virucide

Byotrol PLC

24 May 2023

 

Byotrol Plc

("Byotrol" or the "Company")

EPA approval for

long-lasting performance against viruses

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, is pleased to announce that the US Environmental Protection Agency ("EPA") has formally approved long-lasting virucidal claims for its proprietary 24-hour germ-kill surface sanitizer Byotrol 24 (EPA Reg. Number 83614-1).  This approval was received by the Company after close of business, on 22 May 2023. 

The Directors believe that this is the first product to receive such EPA approval and means that Byotrol24 and its sub brands will now be able to offer unique and highly relevant claims and performance characteristics to US consumers and businesses.   This includes being able to claim efficacy against certain current and emerging viral pathogens including influenza, coronavirus and norovirus (via the commonly accepted surrogate feline calicivirus). 

The Company continues to advance alliances and commercial opportunities in the US, including with a previously announced, well-known sub-licensee in the US institutional market, which is continuing to prepare a market launch with the new product claims at the forefront of its marketing strategy.

 David Traynor, Executive Director,  Byotrol plc comments:

 "This is fantastic news for Byotrol and confirms the excellence of our US surface sanitizers. 

Customers and consumers are now as concerned about protecting against viruses as well as bacteria.  This new approval means we can now make specific long-lasting efficacy claims against viruses, which should in turn significantly increase the commercial potential of our US formulations."

For further information contact:

Byotrol Plc
David Traynor, Executive Director Dr Trevor Francis, Non- Executive Chairman	[phone]
Vivan Pinto, Chief Executive Officer Chris Sedwell, Chief Financial Officer
finnCap Limited (Nominated Adviser and Broker)	[phone]
Geoff Nash/George Dollemore - Corporate Finance Nigel Birks/Harriet Ward - ECM
Flagstaff Strategic and Investor Communications	[phone]
Tim Thompson/Andrea Seymour/Fergus Mellon	[e-mail]

This announcement is released by Byotrol Plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Notes to editors

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, go to byotrol.com

 

END